Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept + Methotrexate in Active Rheumatoid Arthritis
NCT00048568Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2002
- Primary completion
- Oct 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of abatacept in rheumatoid arthritis (RA) (3 arms), sponsored by Bristol Myers Squibb. Primary endpoints: American College of Rheumatology 20 Response at Day 169, Health Assessment Questionnaire Disability Index at Day 365 and 3 more. Started Dec 2002; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00048568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048568.